Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study.

Lingaiah S, Morin-Papunen L, Risteli J, Tapanainen JS.

Fertil Steril. 2019 Aug;112(2):362-370. doi: 10.1016/j.fertnstert.2019.04.013. Epub 2019 Jun 18.

PMID:
31227287
2.

Serum retinol-binding protein 4 levels in polycystic ovary syndrome.

Lingaiah S, Morin-Papunen L, Piltonen T, Sundström-Poromaa I, Stener-Victorin E, Tapanainen JS.

Endocr Connect. 2019 Jun 1;8(6):709-717. doi: 10.1530/EC-19-0116.

3.

Bone markers in polycystic ovary syndrome: A multicentre study.

Lingaiah S, Morin-Papunen L, Piltonen T, Puurunen J, Sundström-Poromaa I, Stener-Victorin E, Bloigu R, Risteli J, Tapanainen JS.

Clin Endocrinol (Oxf). 2017 Dec;87(6):673-679. doi: 10.1111/cen.13456. Epub 2017 Sep 21.

PMID:
28845895

Supplemental Content

Loading ...
Support Center